Loading…

Loading grant details…

Active HORIZON European Commission

POINT OF CARE ULTRASOUND FOR PEDIATRIC LOWER RESPIRATORY TRACT INFECTIONS IN SUB-SAHARAN AFRICA

€4.37M EUR

Funder European Commission
Recipient Organization Wits Health Consortium (Pty) Ltd
Country ZA
Start Date Apr 01, 2024
End Date Sep 30, 2028
Duration 1,643 days
Number of Grantees 10
Roles Participant; Coordinator; Associated Partner
Data Source European Commission
Grant ID 101145822
Grant Description

IMCI-PLUS is an inter-disciplinary, Pan-African-EU research partnership, with emphasis on capacity strengthening and mutual learning, to improve management of pediatric lower respiratory tract infections (LRTI)–the leading cause of child morbidity and mortality in Sub-Saharan Africa (SSA)–by working towards the adoption of point of care lung ultrasound (PLUS) into healthcare policy and routine clinical practice.

Current Integrated Management of Childhood Illnesses (IMCI) guidelines fail to differentiate between uncommon severe bacterial infections and more ubiquitous self-limited viral illnesses; inappropriate antibiotic use is thus widespread and a key driver of antimicrobial resistance. Equally, tuberculosis cases are missed.

The World Health Organization has identified the rigorous evaluation of PLUS to treat children with LRTI as a research priority, especially its health/economic impacts and operational barriers.Including diverse settings within 3 SSA countries (Senegal, South Africa, Tanzania), IMCI-PLUS determines real-life health (antibiotic prescription and clinical outcomes) and economic (cost and cost-effectiveness) impact of integrating PLUS into LRTI management through a prospective randomised controlled trial, combined with evidence from implementation research among 8500 children.

Stakeholder engagement to assess acceptability and feasibility informs a co-designed implementation package with key uptake barriers explored and addressed. A main barrier—healthcare provider skills gaps—is innovated through AI-enabled automated PLUS interpretation.

IMCI-PLUS generates tailored clinical decision tools integrating PLUS to manage LRTI syndromes across a range of epidemiological and healthcare settings.

A comprehensive, integrated translational research framework, focusing on mutual learning by involving stakeholders and patients meaningfully during all evidence generation and translation stages, enables adoption of research findings into policy and practice.

All Grantees

Muhimbili University of Health and Allied Sciences; Wits Health Consortium (Pty) Ltd; Universitaet Bern; The Registered Trustees of the Ifakara Health Institute; Schweizerisches Tropen Und Public Health Institut; African Institute for Mathematicalsciences-Next Einstein Initiative Foundation; Erasmus Universitair Medisch Centrum Rotterdam; Bfly Operations, Inc; Universite Cheikh Anta Diop de Dakar; Stellenbosch University

Advertisement
Apply for grants with GrantFunds
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant